These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Sensory and sympathetic nerve fibers undergo sprouting and neuroma formation in the painful arthritic joint of geriatric mice. Jimenez-Andrade JM; Mantyh PW Arthritis Res Ther; 2012 May; 14(3):R101. PubMed ID: 22548760 [TBL] [Abstract][Full Text] [Related]
8. NGF blockade at early times during bone cancer development attenuates bone destruction and increases limb use. McCaffrey G; Thompson ML; Majuta L; Fealk MN; Chartier S; Longo G; Mantyh PW Cancer Res; 2014 Dec; 74(23):7014-23. PubMed ID: 25287160 [TBL] [Abstract][Full Text] [Related]
9. Exuberant sprouting of sensory and sympathetic nerve fibers in nonhealed bone fractures and the generation and maintenance of chronic skeletal pain. Chartier SR; Thompson ML; Longo G; Fealk MN; Majuta LA; Mantyh PW Pain; 2014 Nov; 155(11):2323-36. PubMed ID: 25196264 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Chapurlat RD; Gensburger D; Jimenez-Andrade JM; Ghilardi JR; Kelly M; Mantyh P Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S3. PubMed ID: 22640953 [TBL] [Abstract][Full Text] [Related]
11. Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers. Ghilardi JR; Freeman KT; Jimenez-Andrade JM; Mantyh WG; Bloom AP; Bouhana KS; Trollinger D; Winkler J; Lee P; Andrews SW; Kuskowski MA; Mantyh PW Bone; 2011 Feb; 48(2):389-98. PubMed ID: 20854944 [TBL] [Abstract][Full Text] [Related]
12. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Sevcik MA; Ghilardi JR; Peters CM; Lindsay TH; Halvorson KG; Jonas BM; Kubota K; Kuskowski MA; Boustany L; Shelton DL; Mantyh PW Pain; 2005 May; 115(1-2):128-41. PubMed ID: 15836976 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of nerve growth factor by murine smooth muscle cells: role of the p75 neurotrophin receptor on sympathetic and sensory sprouting. Petrie CN; Smithson LJ; Crotty AM; Michalski B; Fahnestock M; Kawaja MD J Comp Neurol; 2013 Aug; 521(11):2621-43. PubMed ID: 23322532 [TBL] [Abstract][Full Text] [Related]
15. Targeting nerve growth factor in pain: what is the therapeutic potential? Watson JJ; Allen SJ; Dawbarn D BioDrugs; 2008; 22(6):349-59. PubMed ID: 18998753 [TBL] [Abstract][Full Text] [Related]
16. The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A. Castañeda-Corral G; Jimenez-Andrade JM; Bloom AP; Taylor RN; Mantyh WG; Kaczmarska MJ; Ghilardi JR; Mantyh PW Neuroscience; 2011 Mar; 178():196-207. PubMed ID: 21277945 [TBL] [Abstract][Full Text] [Related]
17. Intraventricular infusion of nerve growth factor as the cause of sympathetic fiber sprouting in sensory ganglia. Nauta HJ; Wehman JC; Koliatsos VE; Terrell MA; Chung K J Neurosurg; 1999 Sep; 91(3):447-53. PubMed ID: 10470820 [TBL] [Abstract][Full Text] [Related]
18. Bone cancer pain: causes, consequences, and therapeutic opportunities. Mantyh P Pain; 2013 Dec; 154 Suppl 1():S54-S62. PubMed ID: 23916671 [TBL] [Abstract][Full Text] [Related]
19. Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur. Koewler NJ; Freeman KT; Buus RJ; Herrera MB; Jimenez-Andrade JM; Ghilardi JR; Peters CM; Sullivan LJ; Kuskowski MA; Lewis JL; Mantyh PW J Bone Miner Res; 2007 Nov; 22(11):1732-42. PubMed ID: 17638576 [TBL] [Abstract][Full Text] [Related]
20. Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor. Eibl JK; Strasser BC; Ross GM Neurochem Int; 2012 Dec; 61(8):1266-75. PubMed ID: 23103525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]